Physician

Thomas Joseph Meskey, M.D.

According to 2025 Medicare claims, Thomas Meskey, M.D. (NPI: 1750649109) practices dermatology in the York-Hanover, PA market, with the plurality of this provider's patient population coming from York, PA. This provider's primary affiliated billing organization is DERMATOLOGY ASSOCIATES OF YORK INC (NPI: 1245204023; TIN: 232143100) and primary practice location at 17402-4643.

Meskey's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,413 traditional Medicare patients, billed 6,084 HCPCS/CPT codes, and received $319,795 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,214 prescription claims across 535 beneficiaries totaling $521,937 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 10 records totaling $215. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $291,605 to $521,937. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	670	2,464	$112,490
2017	1,120	4,811	$226,940
2018	1,447	7,188	$330,770
2019	1,705	10,068	$466,349
2020	1,643	9,546	$397,987
2021	1,308	4,888	$249,752
2022	1,176	4,380	$254,567
2023	1,456	6,050	$311,823
2024	1,413	6,084	$319,795

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	141	441	$291,605
2016	181	424	$189,762
2017	255	572	$41,138
2018	322	694	$39,228
2019	371	822	$50,657
2020	386	806	$45,425
2021	352	705	$100,594
2022	365	766	$259,164
2023	467	1,011	$374,502
2024	535	1,214	$521,937

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	351	385	$75
11102	Biopsy of related skin growth, first growth	499	553	$63
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	755	863	$59
17000	Destruction of precancer skin growth, 1 growth	505	577	$32
17003	Destruction of precancer skin growth, 2-14 growths	375	1,711	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Pen	Dupilumab	24	658	$89,547
Otezla	Apremilast	12	356	$58,243
Clobetasol Propionate	Clobetasol Propionate	119	3,299	$7,724
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	139	4,186	$5,197
Fluorouracil	Fluorouracil	33	1,041	$2,263

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$215	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Thomas Joseph Meskey, M.D.?

Tedicare shows public-source Medicare data for Thomas Joseph Meskey, M.D. (NPI 1750649109), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas Joseph Meskey, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Thomas Joseph Meskey, M.D.?

Thomas Joseph Meskey, M.D. is linked to DERMATOLOGY ASSOCIATES OF YORK INC (billing NPI 1245204023) in the available physician profile data.

Does Thomas Joseph Meskey, M.D. have Open Payments data?

Thomas Joseph Meskey, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.